The Use of Domperidone for Gastroparesis
NCT01378884 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-03-19
Summary
The purpose of this study is to determine whether domperidone can be used safely and effectively for patient with gastroparesis.
Conditions
Interventions
- DRUG
-
Domperidone
Patient to receive treatment with Domperidone
Sponsors & Collaborators
-
Allegiance Health
lead OTHER
Principal Investigators
-
Ivan Cubas, MD · Allegiance Health Gastroenterology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2012-03-31
- Completion
- 2014-03-31
More Related Trials
-
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
NCT01173484 ·Status: TERMINATED
-
Study of Motilitone to Treat Functional Dyspepsia
NCT02365701 ·Status: COMPLETED ·Phase: PHASE2
-
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
NCT02232308 ·Status: COMPLETED ·Phase: PHASE1
-
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT03617016 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
NCT02151708 ·Status: UNKNOWN ·Phase: NA
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
NCT07324785 ·Status: RECRUITING
-
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
NCT01316484 ·Status: COMPLETED
-
Study of Gastric Motility in Eosinophilic Gastritis
NCT05229432 ·Status: RECRUITING
-
Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
NCT06854120 ·Status: NOT_YET_RECRUITING
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Haloperidol vs Conventional Therapy for Gastroparesis
NCT02057549 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Demonstrate the Efficacy and Safety of Motilitone®
NCT01817465 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Motilitone on Gastric Motor Function in Healthy Volunteers
NCT01719575 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
NCT01114113 ·Status: WITHDRAWN ·Phase: NA
-
Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome
NCT03263819 ·Status: COMPLETED
-
Gastroparesis Registry 3
NCT03680859 ·Status: COMPLETED
-
Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia
NCT05055336 ·Status: WITHDRAWN ·Phase: NA
-
GI Tolerance and Acceptability of a New Thickener
NCT04104815 ·Status: WITHDRAWN ·Phase: NA
-
G-POEM vs PEG-J in Gastroparesis Patients
NCT06372132 ·Status: RECRUITING ·Phase: NA
-
Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial
NCT06173336 ·Status: WITHDRAWN ·Phase: NA
-
IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach
NCT01858220 ·Status: UNKNOWN
-
Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis
NCT06411574 ·Status: RECRUITING ·Phase: NA
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA